• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminotoluenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Aminotoluenes

Professional Introduction to N~1~,N~1~,4-Trimethyl-1,2-benzenediamine (CAS No. 183251-82-3)

N~1~,N~1~,4-Trimethyl-1,2-benzenediamine is a significant compound in the field of pharmaceutical chemistry, characterized by its unique molecular structure and diverse potential applications. This compound, identified by the CAS number 183251-82-3, has garnered attention due to its structural complexity and its role as a precursor in the synthesis of various pharmacologically active molecules. The presence of multiple methyl and amine functional groups makes it a versatile intermediate in organic synthesis, particularly in the development of novel therapeutic agents.

The molecular formula of N~1~,N~1~,4-Trimethyl-1,2-benzenediamine is C?H??N?, reflecting its aromatic backbone with three methyl substituents and two amine groups. This configuration imparts a high degree of reactivity, enabling it to participate in a wide range of chemical transformations. The compound's stability under various conditions further enhances its utility in synthetic protocols. Recent studies have highlighted its importance in the synthesis of complex heterocyclic compounds, which are increasingly being explored for their medicinal properties.

In the realm of drug discovery, N~1~,N~1~,4-Trimethyl-1,2-benzenediamine has been utilized as a building block for more intricate molecules. Its ability to undergo selective functionalization allows researchers to tailor the properties of derived compounds for specific therapeutic targets. For instance, derivatives of this compound have shown promise in the development of kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The amine groups provide nucleophilic centers that can react with electrophilic substrates, facilitating the introduction of additional functional moieties.

Recent advancements in computational chemistry have further illuminated the potential of N~1~,N~1~,4-Trimethyl-1,2-benzenediamine. Molecular modeling studies suggest that this compound can form stable complexes with biological targets, enhancing drug delivery and efficacy. These simulations have guided experimental efforts, leading to more efficient synthetic routes and improved yields. The integration of machine learning algorithms has also enabled the prediction of novel derivatives with enhanced pharmacological profiles.

The pharmaceutical industry has been particularly interested in exploring the therapeutic potential of N~1~,N~1~,4-Trimethyl-1,2-benzenediamine derivatives. Preclinical studies have demonstrated that certain analogs exhibit significant anti-inflammatory and analgesic properties. These findings have prompted further investigation into their mechanisms of action, aiming to identify lead compounds for clinical development. The compound's structural features make it an attractive candidate for modulating enzyme activity and receptor binding interactions.

Industrial applications of N~1~,N~1~,4-Trimethyl-1,2-benzenediamine extend beyond pharmaceuticals. Its role as a precursor in agrochemical synthesis has been explored, particularly in the development of novel herbicides and pesticides. The compound's reactivity allows for the creation of derivatives with enhanced environmental stability and biodegradability. Such developments are crucial in addressing the growing need for sustainable agricultural practices.

Environmental considerations have also driven research into greener synthetic methods for N~1~,N~1~,4-Trimethyl-1,2-benzenediamine production. Catalytic processes have been optimized to minimize waste and energy consumption while maintaining high yields. These innovations align with global efforts to promote sustainable chemistry practices. Additionally, biocatalytic approaches using engineered enzymes have shown promise in facilitating selective transformations without harsh chemical conditions.

The future prospects for N~1~,N~1~,4-Trimethyl-1,2-benzenediamine are promising, with ongoing research uncovering new applications and synthetic strategies. Collaborative efforts between academia and industry are essential to translate laboratory discoveries into practical solutions for societal challenges. As our understanding of molecular interactions deepens, so too does our ability to harness this compound's potential for innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)